Rua Life Sciences Debt 2024

Rua Life Sciences Aktienanalyse

What does Rua Life Sciences do?

Rua Life Sciences PLC is a British company specializing in the development and manufacture of therapeutics and medical devices in the pharmaceutical industry. It was founded in 1999 by Dr. Ahmed Abdullah as Research Chemicals International. In 2007, it was renamed Rua Life Sciences PLC and has been listed on the London Stock Exchange since 2014. The business model of Rua Life Sciences PLC is the research and development of pharmaceuticals. The company invests in the discovery of new active substances and technologies that can be used to treat diseases. In addition, Rua Life Sciences PLC is also involved in the storage and transportation of pharmaceutical products. The product range of Rua Life Sciences PLC includes various areas such as oncology, neurology, ophthalmology, infectious diseases, and cardiovascular diseases. In oncology research, the company works on innovative approaches to the treatment of various types of cancer. This includes the development of drugs to combat breast cancer or lung cancer. In neurology, Rua Life Sciences PLC aims to develop new therapeutics for the treatment of diseases of the nervous system. This includes, among other things, drugs for the relief of Parkinson's or Alzheimer's. In the field of ophthalmology, the company researches drugs for the treatment of eye diseases such as macular degeneration, which leads to vision impairment in older people. This also includes testing new technologies such as the combination of drugs with special apparatus. In infectious diseases research, Rua Life Sciences PLC works on drugs to combat viruses and bacteria that can cause various diseases. This also includes the development of vaccines to counter epidemic outbreaks. Another important area for Rua Life Sciences PLC is research in the field of cardiovascular diseases. The company is working on drugs to treat hypertension, heart attacks, and other cardiovascular diseases. In addition to pharmaceutical products and therapeutics, Rua Life Sciences PLC also offers medical devices. These include blood glucose meters and medical inhalers used in the treatment of respiratory diseases. The company aims to help patients worldwide and save lives. It invests large sums in the research and development of therapeutics and medical devices to improve healthcare for humans and animals. Rua Life Sciences PLC collaborates with leading scientists and biomedical companies and maintains a network of partners around the world. Overall, Rua Life Sciences PLC is a company with a wide product range specializing in the manufacture of pharmaceuticals and medical devices. The company is committed to healing diseases and improving the health of people worldwide. Rua Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Rua Life Sciences's Debt Structure

Rua Life Sciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Rua Life Sciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Rua Life Sciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Rua Life Sciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Rua Life Sciences stock

What is the debt of Rua Life Sciences this year?

Rua Life Sciences has a debt level of -2.49 GBP this year.

What was the debt of Rua Life Sciences compared to the previous year?

The debt of Rua Life Sciences has increased by -5% compared to the previous year dropped.

What are the consequences of high debt for investors in Rua Life Sciences?

High debt can pose a risk for investors of Rua Life Sciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Rua Life Sciences?

Low debt means that Rua Life Sciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Rua Life Sciences affect the company?

An increase in debt of Rua Life Sciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Rua Life Sciences affect the company?

A reduction in debt of Rua Life Sciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Rua Life Sciences?

Some factors that can influence the debt of Rua Life Sciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Rua Life Sciences so important for investors?

The debts of Rua Life Sciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Rua Life Sciences take to change the debt?

To change the debt, Rua Life Sciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Rua Life Sciences pay?

Over the past 12 months, Rua Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rua Life Sciences is expected to pay a dividend of 0 GBP.

What is the dividend yield of Rua Life Sciences?

The current dividend yield of Rua Life Sciences is .

When does Rua Life Sciences pay dividends?

Rua Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rua Life Sciences?

Rua Life Sciences paid dividends every year for the past 0 years.

What is the dividend of Rua Life Sciences?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Rua Life Sciences located?

Rua Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rua Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rua Life Sciences from 8/26/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 8/26/2024.

When did Rua Life Sciences pay the last dividend?

The last dividend was paid out on 8/26/2024.

What was the dividend of Rua Life Sciences in the year 2023?

In the year 2023, Rua Life Sciences distributed 0 GBP as dividends.

In which currency does Rua Life Sciences pay out the dividend?

The dividends of Rua Life Sciences are distributed in GBP.